
Bimator0.03%+0.5%
Square Pharmaceuticals PLC.
Bimatoprost + Timolol is a fixed-dose combination ophthalmic solution (bimatoprost, a prostaglandin analog, plus timolol and more.
Bimatoprost + Timolol is a fixed-dose combination ophthalmic solution (bimatoprost, a prostaglandin analog, plus timolol, a non-selective beta-blocker) indicated for the following:
Bimatoprost + Timolol is intended for patients who need more IOP reduction than a single agent (either bimatoprost alone or timolol alone) provides; it is not typically used as first-line monotherapy when a single agent would be adequate, since combination therapy carries a broader side-effect profile from both components.
One drop of Bimatoprost + Timolol in the affected eye(s) once daily, in the morning. Do not exceed the recommended once-daily dosing frequency; more frequent dosing may actually reduce the IOP-lowering effect of the bimatoprost component.
Safety and efficacy of Bimatoprost + Timolol have not been established in pediatric patients; it is not recommended for use in children (see Use in Special Populations).
No specific dose adjustment of Bimatoprost + Timolol has been established for renal or hepatic impairment; use with appropriate caution regarding the systemic beta-blocker effects of the timolol component in patients with significant organ impairment, under physician guidance.
Bimatoprost + Timolol is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.